BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019

Nov 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-11-05

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-05	Common Stock	G	450	$0.00	Disposed	327070	Direct
2019-11-11	Common Stock	L	10	$75.3786	Acquired	327080	Direct
2019-11-22	Common Stock	M	10000	$21.51	Acquired	337080	Direct
2019-11-22	Common Stock	S	10000	$77.60	Disposed	327080	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-22	Stock Option (Right to buy Common Stock)	$21.51	M	6000	Disposed	2020-05-11	Common Stock (6000)	Direct
2019-11-22	Stock Option (Right to buy Common Stock)	$21.51	M	4000	Disposed	2020-05-11	Common Stock (4000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	181341	Indirect

Footnotes

F1: On November 5, 2019 the reporting person gifted 450 shares to an educational institution.

F2: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F3: Trade made pursuant to 10b5-1 plans executed on June 11, 2019 and September 6, 2019.

F4: Reflects the number of options outstanding after the transactions from this specific stock option grant.